Abraxis

LARGELY as a result of investor enthusiasm for Abraxane, the stock market value of Abraxis is $4.6 billion.

Democracy's Vices, Arnold Kling | EconLog | Library of Economics and Liberty 2009

Now Abraxis is asking the F.D.A. to allow the use of Abraxane as a treatment for early-stage breast cancer, a larger market than that for late-stage treatments.

Democracy's Vices, Arnold Kling | EconLog | Library of Economics and Liberty 2009

With Abraxis, which is based in East Schaumburg, Ill., it has added solid-tumor treatments to the blood-related, or "liquid tumor" cancer drugs that launched the company.

Celgene's Acquisition Now Looks Brilliant - Yahoo! Finance 2010

BioSciences Inc. ( "Abraxis" or the "Company") (NasdaqGS: ABII) by Celgene Corporation

Business Wire Travel News 2010

( "Abraxis") to fund the operating runway for 2010, and to repay a significant amount of the other debt borrowed to fund the business during 2009.

Marketwire - Breaking News Releases 2010

BioScience, Inc. ( "Abraxis" or the "Company") (NASDAQ: ABII) related to the Company's agreement to be acquired by Celgene Corporation ( "Celgene").

Business Wire Travel News 2010

On the prose front, I write the Abraxis Wren series for Wizards of the Coast.

2010 January « 2010

Mr. Hugin said the company is more optimistic about the drug's potential in Europe than when it made the Abraxis deal last year, as it has learned about the reimbursement issues, along with the approved uses in the region.

Celgene Profit Drops 16% as Revenue Jumps Thomas Gryta 2011

The increase comes from related costs from the Abraxis deal, including from some operations that will be divested, and multiple clinical development programs in its product pipeline.

Celgene Profit Drops 16% as Revenue Jumps Thomas Gryta 2011

On the prose front, I write the Abraxis Wren series for Wizards of the Coast.

Oh, a writer’s life for me… « 2010